呼吸系统诊断市场－全球产业规模、份额、趋势、机会和预测，按类型、检测类型、疾病适应症、最终用途、地区和竞争格局划分，2020-2030年预测

2024年全球呼吸系统诊断市场规模为60.2亿美元，预计2030年将以7.10%的复合年增长率成长至90.9亿美元。全球呼吸系统诊断市场涵盖了用于识别、监测和管理呼吸系统疾病（包括气喘、慢性阻塞性肺病和各种感染）的各种医疗检测、设备、分析方法和服务。该市场的成长主要受以下因素驱动：全球呼吸系统疾病盛行率不断上升、老年人口不断增长且更容易患上此类疾病，以及不断提高诊断精度和效率的技术进步。

主要市场驱动因素

呼吸系统疾病日益普遍，是全球呼吸系统诊断市场的主要驱动力，直接刺激了对综合诊断解决方案的需求。气喘、慢性阻塞性肺病和各种感染等疾病持续对全球公共卫生构成重大挑战，因此需要及时且准确地进行检测，以有效管理患者。

主要市场挑战

先进诊断设备所需的大量资本投入直接阻碍了全球呼吸系统诊断市场的成长。医疗系统和医疗服务提供者，尤其是在新兴经济体，面临着巨大的预算限制，这限制了他们购买和升级此类关键技术的能力。

主要市场趋势

人工智慧和机器学习在诊断领域的应用显着提升了疾病检测的精准度和效率，从而大大重塑了全球呼吸系统诊断市场。这些先进的计算方法能够快速分析复杂资料，比传统方法更早地识别出提示呼吸系统疾病的细微模式。

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球呼吸系统诊断市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按类型（仪器和设备、检测和试剂、服务和软体）
  • 按测试类型（机械测试、OSA诊断测试、影像测试、传统诊断测试、分子诊断测试）
  • 依疾病适应症分类（结核病、气喘、肺癌、慢性阻塞性肺病、其他）
  • 依最终用途（医院和诊所、诊断实验室、其他）
  • 按地区
  • 按公司（2024 年）
• 市场地图

第六章：北美呼吸系统诊断市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲呼吸系统诊断市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区呼吸道诊断市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲呼吸系统诊断市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美洲呼吸系统诊断市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章：全球呼吸系统诊断市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• Koninklijke Philips NV
• Becton, Dickinson and Company
• Thermo Fisher Scientific Inc.
• Abbott Laboratories Inc.
• Dragerwerk AG & Co. KGaA
• Siemens Healthineers AG
• PerkinElmer Inc.
• India Medtronic Private Limited
• Bio-Rad Laboratories, Inc.
• GE HealthCare Technologies Inc.

第十六章：策略建议

第17章调查会社について・免责事项

The Global Respiratory Diagnostics Market, valued at USD 6.02 Billion in 2024, is projected to experience a CAGR of 7.10% to reach USD 9.09 Billion by 2030. The global respiratory diagnostics market encompasses a diverse range of medical tests, devices, assays, and services utilized for the identification, monitoring, and management of conditions affecting the respiratory system, including asthma, chronic obstructive pulmonary disease, and various infections. This market's expansion is primarily driven by the escalating worldwide prevalence of respiratory diseases, the growing elderly population exhibiting higher susceptibility to such conditions, and continuous technological advancements that enhance diagnostic precision and efficiency.

Key Market Drivers

The increasing prevalence of respiratory diseases represents a fundamental driver for the global respiratory diagnostics market, directly stimulating the demand for comprehensive diagnostic solutions. Conditions such as asthma, chronic obstructive pulmonary disease, and various infections continue to pose substantial public health challenges worldwide, necessitating timely and accurate detection for effective patient management. As populations grow and environmental factors contribute to disease incidence, the imperative for robust diagnostic capabilities intensifies.

Key Market Challenges

The significant capital investment needed for advanced diagnostic equipment directly impedes the growth of the Global Respiratory Diagnostics Market. Healthcare systems and providers, particularly within emerging economies, face considerable budget constraints that limit their capacity to acquire and upgrade such essential technology. This financial barrier often delays the adoption of new, more effective diagnostic solutions, thereby restricting overall market expansion.

Key Market Trends

The integration of Artificial Intelligence and Machine Learning in diagnostics significantly reshapes the Global Respiratory Diagnostics Market by enhancing the precision and efficiency of disease detection. These advanced computational methods enable rapid analysis of complex data, identifying subtle patterns indicative of respiratory conditions earlier than traditional means.

Key Market Players

• Koninklijke Philips N.V
• Becton, Dickinson and Company
• Thermo Fisher Scientific Inc.
• Abbott Laboratories Inc.
• Dragerwerk AG & Co. KGaA
• Siemens Healthineers AG
• PerkinElmer Inc.
• India Medtronic Private Limited
• Bio-Rad Laboratories, Inc.
• GE HealthCare Technologies Inc.

Report Scope:

In this report, the Global Respiratory Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Respiratory Diagnostics Market, By Type:

• Instruments and Devices
• Assays & Reagents
• Services & Software

Respiratory Diagnostics Market, By Test Type:

• Mechanical Tests
• OSA Diagnostic Test
• Imaging Tests
• Traditional Diagnostic Test
• Molecular Diagnostic Tests

Respiratory Diagnostics Market, By Disease Indication:

• Tuberculosis
• Asthma
• Lung Cancer
• Chronic Obstructive Pulmonary Disease
• Others

Respiratory Diagnostics Market, By End-Use:

• Hospitals and Clinics
• Diagnostics Laboratory
• Others

Respiratory Diagnostics Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Respiratory Diagnostics Market.

Available Customizations:

Global Respiratory Diagnostics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Respiratory Diagnostics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Instruments and Devices, Assays & Reagents, Services & Software)
  • 5.2.2. By Test Type (Mechanical Tests, OSA Diagnostic Test, Imaging Tests, Traditional Diagnostic Test, Molecular Diagnostic Tests)
  • 5.2.3. By Disease Indication (Tuberculosis, Asthma, Lung Cancer, Chronic Obstructive Pulmonary Disease, Others)
  • 5.2.4. By End-Use (Hospitals and Clinics, Diagnostics Laboratory, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America Respiratory Diagnostics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Test Type
  • 6.2.3. By Disease Indication
  • 6.2.4. By End-Use
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Respiratory Diagnostics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Test Type
      • 6.3.1.2.3. By Disease Indication
      • 6.3.1.2.4. By End-Use
  • 6.3.2. Canada Respiratory Diagnostics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Test Type
      • 6.3.2.2.3. By Disease Indication
      • 6.3.2.2.4. By End-Use
  • 6.3.3. Mexico Respiratory Diagnostics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Test Type
      • 6.3.3.2.3. By Disease Indication
      • 6.3.3.2.4. By End-Use

7. Europe Respiratory Diagnostics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Test Type
  • 7.2.3. By Disease Indication
  • 7.2.4. By End-Use
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Respiratory Diagnostics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Test Type
      • 7.3.1.2.3. By Disease Indication
      • 7.3.1.2.4. By End-Use
  • 7.3.2. France Respiratory Diagnostics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Test Type
      • 7.3.2.2.3. By Disease Indication
      • 7.3.2.2.4. By End-Use
  • 7.3.3. United Kingdom Respiratory Diagnostics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Test Type
      • 7.3.3.2.3. By Disease Indication
      • 7.3.3.2.4. By End-Use
  • 7.3.4. Italy Respiratory Diagnostics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Test Type
      • 7.3.4.2.3. By Disease Indication
      • 7.3.4.2.4. By End-Use
  • 7.3.5. Spain Respiratory Diagnostics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Test Type
      • 7.3.5.2.3. By Disease Indication
      • 7.3.5.2.4. By End-Use

8. Asia Pacific Respiratory Diagnostics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Test Type
  • 8.2.3. By Disease Indication
  • 8.2.4. By End-Use
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Respiratory Diagnostics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Test Type
      • 8.3.1.2.3. By Disease Indication
      • 8.3.1.2.4. By End-Use
  • 8.3.2. India Respiratory Diagnostics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Test Type
      • 8.3.2.2.3. By Disease Indication
      • 8.3.2.2.4. By End-Use
  • 8.3.3. Japan Respiratory Diagnostics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Test Type
      • 8.3.3.2.3. By Disease Indication
      • 8.3.3.2.4. By End-Use
  • 8.3.4. South Korea Respiratory Diagnostics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Test Type
      • 8.3.4.2.3. By Disease Indication
      • 8.3.4.2.4. By End-Use
  • 8.3.5. Australia Respiratory Diagnostics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Test Type
      • 8.3.5.2.3. By Disease Indication
      • 8.3.5.2.4. By End-Use

9. Middle East & Africa Respiratory Diagnostics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Test Type
  • 9.2.3. By Disease Indication
  • 9.2.4. By End-Use
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Respiratory Diagnostics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Test Type
      • 9.3.1.2.3. By Disease Indication
      • 9.3.1.2.4. By End-Use
  • 9.3.2. UAE Respiratory Diagnostics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Test Type
      • 9.3.2.2.3. By Disease Indication
      • 9.3.2.2.4. By End-Use
  • 9.3.3. South Africa Respiratory Diagnostics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Test Type
      • 9.3.3.2.3. By Disease Indication
      • 9.3.3.2.4. By End-Use

10. South America Respiratory Diagnostics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Test Type
  • 10.2.3. By Disease Indication
  • 10.2.4. By End-Use
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Respiratory Diagnostics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Test Type
      • 10.3.1.2.3. By Disease Indication
      • 10.3.1.2.4. By End-Use
  • 10.3.2. Colombia Respiratory Diagnostics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Test Type
      • 10.3.2.2.3. By Disease Indication
      • 10.3.2.2.4. By End-Use
  • 10.3.3. Argentina Respiratory Diagnostics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Test Type
      • 10.3.3.2.3. By Disease Indication
      • 10.3.3.2.4. By End-Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Respiratory Diagnostics Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Koninklijke Philips N.V
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Becton, Dickinson and Company
• 15.3. Thermo Fisher Scientific Inc.
• 15.4. Abbott Laboratories Inc.
• 15.5. Dragerwerk AG & Co. KGaA
• 15.6. Siemens Healthineers AG
• 15.7. PerkinElmer Inc.
• 15.8. India Medtronic Private Limited
• 15.9. Bio-Rad Laboratories, Inc.
• 15.10. GE HealthCare Technologies Inc.

16. Strategic Recommendations

17. About Us & Disclaimer